Skip to main content
Premium Trial:

Request an Annual Quote

LetsGetChecked Partners With California Department of Public Health for COVID-19 Sequencing

NEW YORK – Digital care company LetsGetChecked said on Tuesday that it has partnered with the California Department of Public Health's SARS-CoV-2 Whole Genome Sequencing Initiative, or COVIDNet, to help identify and trace COVID-19 variants in the US population.

As part of the collaboration, the firm, which has headquarters in New York and Dublin, will use its CAP-accredited, CLIA-certified lab in Monrovia, California and Illumina's NovaSeq 6000 system to sequence SARS-CoV-2 samples and spot different variants of the virus.

LetsGetChecked will sequence the genomes of positive samples collected in California that were detected using its molecular coronavirus test or provided by COVIDNet. The goal is to sequence 40,000 positive samples per month.

"We congratulate LetsGetChecked on their expansion into sequencing to help the country stay ahead of emergence and spread of harmful variants," Phil Febbo, chief medical officer of Illumina, said in a statement. "This is an exciting example of innovation in response to the evolving demands of the pandemic and the need for public-private partnerships to support our incredible public health teams."

Financial details of the agreement were not disclosed.

CDPH has partnered with local public health labs, diagnostic labs, the Chan Zuckerberg Biohub, Invitae, the University of California, San Francisco, and the Scripps Research Institute to form COVIDNet.

Earlier this month, LetsGetChecked closed a $150 million funding round.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.